front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |review |
Limitations of other data
sources are as follows:
Vital statistics data: These data cannot be used to monitor
diseases with low case-mortality rates like arthritis. As well,
cause of death is rarely attributed to a chronic disease itself, but
rather to complications that arise from having the disease. Vital
statistics data are not always a timely source of information on
disease prevalence because of potentially long lag times between
changes in the population prevalence of a disease and its detection
using mortality data.
Disease-specific clinical
registries:
While clinical registries can usually provide accurate
estimates of disease prevalence, they are expensive and
time-consuming to establish and maintain, and are being subjected to
increased scrutiny under current health privacy legislation. As
well, registries which are specific to particular geographic areas,
clinical groups, or facilities do not provide estimates of incidence
or prevalence that can be generalized to larger populations.
Survey data: population-based health surveys,
another well-established source of chronic disease data, may suffer
from non-response bias, which can result in inaccurate estimates of
incidence and prevalence. Longitudinal survey data, which are useful
for estimating disease incidence, often suffer from bias due to
participant attrition.
|